Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Sı́lvia Beà(Departament de Salut), Elı́as Campo(Hospital Clínic de Barcelona), Pedro Jares(Hospital Clínic de Barcelona), Guillem Clot(Aristotle University of Thessaloniki), Mònica López‐Guerra(Centro de Investigación Biomédica en Red de Cáncer), Luís Hernández(Technological Institute of Celaya), Luís Colomo(Hospital Del Mar), Armando López‐Guillermo(Barcelona Supercomputing Center), José I. Martín‐Subero(Institució Catalana de Recerca i Estudis Avançats), Virginia Amador(Centro de Investigación Biomédica en Red de Cáncer), Neus Villamor(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Adrian Wiestner(National Institutes of Health), Reiner Siebert(Christian-Albrechts-Universität zu Kiel), Jesús María Hernández‐Rivas(Universidad de Salamanca), Gaël Roué(Josep Carreras Leukaemia Research Institute), Luciano Di Croce(Institució Catalana de Recerca i Estudis Avançats), Wyndham H. Wilson(National Institutes of Health), Marta Aymerich(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Eva Giné(Aristotle University of Thessaloniki), Ferran Nadeu(Centro de Investigación Biomédica en Red de Cáncer), Alexandra Moros(Universitat de Barcelona), Elena Hartmann(University of Würzburg), Marı́a Rozman(Universitat de Barcelona), Manel Juan(Hospital Sant Joan de Déu Barcelona), Alexandra Valera(Ente Ospedaliero Cantonale), Antonio Martı́nez(Hospital Universitario de Móstoles), Ana Muntañola(University Hospital Mútua de Terrassa), Itziar Salaverría(Centro de Investigación Biomédica en Red de Cáncer), Magda Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Diana Puente(Universidad de Oviedo), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Cristina Royo(Aristotle University of Thessaloniki), David Martin‐García(Centro de Investigación Biomédica en Red de Cáncer), Rafael Valdés‐Mas(Weizmann Institute of Science), Dolors Colomer(Hospital Clínic de Barcelona), Anna Enjuanes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos López-Otı́n(Inserm), Marı́a José Calasanz(Navarre Institute of Health Research), Xosé S. Puente(Universidad de Oviedo), Alba Navarro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Pedro Vizán(Universitat Pompeu Fabra), Laura Peña Conde(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Pilar Forcada(University Hospital Mútua de Terrassa)
Cited by 519
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k